Marker TherapeuticsMRKR
13F holders, Q1 2024 (March 31)1holders
$4.30avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings. The largest holder was Ar Asset Management Inc. ($304K).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Ar Asset Management Inc. | 0.08% | No change | 70,700 | $304K |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.